Stronger healthcare needs united effort: National workshop
Without quality in every dose, a doctor’s efforts fall short,” Say pharma stakeholders in Karachi
IV Report
KARACHI: Speakers at a national workshop on May 24 underscored the urgent need for unified efforts among pharmaceutical manufacturers, regulatory authorities, and the scientific community to ensure a more vibrant and effective medical supply system in Pakistan.
The one-day workshop, held at the
International Centre for Chemical and Biological Sciences (ICCBS), University
of Karachi, was jointly organised by the Dr Panjwani Centre for Molecular
Medicine and Drug Research (PCMMDR) and the Drug Regulatory Authority of
Pakistan (DRAP). The event drew participation from government officials,
regulators, industry leaders, and academia.
In his address, Tauqeer Ul Haq,
Chairman of the Pakistan Pharmaceutical Manufacturers Association (PPMA),
highlighted the local industry’s robust footprint, stating that more than 700
medicine manufacturing companies were responsible for producing 90 percent of
the country’s drug supply. “The national industry holds a 70 per cent share of
the domestic market,” he added, pointing to the sector’s significant
contribution.
Rehan Iqbal Baloch, Secretary of the Sindh Health Department, acknowledged the persistent demand for essential medicines and urged the pharmaceutical industry to focus on producing these vital drugs for the broader population. He expressed the Sindh government’s willingness to support collaboration between the pharma sector and academic institutions to enhance healthcare product standards.
Prof Dr Muhammad Raza Shah, Director
of ICCBS and UNESCO Chair holder, emphasised the role of science and technology
in national development. “This workshop serves as a critical platform for
regulators, industry leaders, and academics to devise collaborative strategies
that ensure the safety, efficacy, and innovation of healthcare products,” he
noted.
Addressing the inaugural session
titled “The Role of Regulators, Pharma Industry, and Academia in Promoting
Quality Healthcare Products”, Prof Atta-ur Rahman, Professor Emeritus and
former Federal Minister for Science and Technology, called for the creation of
a unified platform integrating manufacturers, exporters, policymakers, and
researchers to explore opportunities and tackle challenges in the healthcare
sector.
In her welcome address, Nadira
Panjwani, Chairperson of the Panjwani Trust—founding body of PCMMDR—praised the
participants and underlined the critical importance of ensuring access to
quality medicines for the nation’s population.
Reflecting on the evolution of medicine, Ms Panjwani described it as a journey “from superstition, spiritual belief, guesswork, and discovery to rigorous research and evidence-based findings.” She highlighted global efforts for harmonising regulatory standards, led by the World Health Organisation and embraced by national and international drug regulatory bodies.
“A doctor may chart the path to
healing, but it is the medicine that carries a patient forward. Without quality
in every dose, a doctor’s efforts will fall short,” she remarked.
She concluded with the hope that the
workshop would strengthen the coordinated role of the three essential pillars
of healthcare—regulators, the pharmaceutical industry, and academia—with the
latter acting as the engine of discovery.
Photos courtesy: PCMMDR
Comments
Post a Comment